BN Business News
Add your company to Business Communicator →

Regulacje i polityka gospodarcza · 02/10/2025

National Center for Advancing Translational Sciences to Grant Exclusive Patent License to Stage One Immunotherapeutics

The National Center for Advancing Translational Sciences is considering granting an exclusive patent license to Stage One Immunotherapeutics, Inc. for its quinoline analogs as Aldehyde Dehydrogenase 1A1 inhibitors.

Source: Federal Register — All DocumentsOpen original release →